Search results for: 'ai infrastructure developments access a9aa processing the digital utility'

The North American dedicated internet access (DIA) services market is mature but has experienced a fresh burst of energy in the past few years as software-defined wide area networks (SD-WAN) challenge the status quo of traditional WAN services. While some customers have chosen to create a hybrid SD-WAN network by adding broadband links to MPLS or E...

A majority of marketers use a demand side platform, or DSP, for digital advertising in the United States. This Frost & Sullivan market insight highlights the key trends in the US DSP market and presents insights into the competitive strategies of leading DSP industry participants. It presents an overview of the key industry challenges and includes ...

The infrastructure as a service and platform as a service (IaaS and PaaS) industry has undergone a significant evolution in the past year. Macroeconomic instability has negatively affected IT investments and cloud spend, ushering in a growing focus on cloud cost optimization. In tandem, the arrival of generative AI (GenAI) on the scene has necessit...

27 Nov 2017  |  North America  |  Market Research

Growth Opportunities in the Global Digital Pathology Market, Forecast to 2021

New Business Models and More FDA Approvals of WSI Scanners for Primary Diagnostics are Set to Boost Growth of Digital Pathology

Infographics

×

Key Issues Addressed

Shortage of pathologists and the rise in new cancer cases are the key drivers for the adoption of digital pathology solutions globally. Digital pathology enhances the productivity of pathologists by 10% to 15%, thereby improving the overall efficiency of healthcare providers. Digital pathology solutions find the best fit in oncology care. Accordin...

The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023, indicating a 5.8% hike over 2022, with more than 6,100 molecules in active development. In general, however, the pharma/biopharma industry has stagnated with respect to R&D activity. Overall R&D expenditure totals about $276....

Artificial Intelligence (AI) is the shining star of contact center innovation and began gaining features, focus, and adoption in 2022. AI is enhancing capabilities across the contact center spectrum: from agent hiring and training, resource forecasting, and quality and performance management to process automation, workforce optimization, and custom...

As clinical pipelines globally witness a surge in novel complex therapies, the clinical trial industry demands new tools in predictive analytics to improve trial design, planning, and execution. Artificial intelligence is gaining large-scale recognition as support for decentralized trial designs, thus enabling patient-centric clinical trial designs...

This Frost & Sullivan research examines the growing need for artificial intelligence (AI) services to help businesses meet key goals and objectives, as well as the strategic position of public cloud service providers to develop and launch successful AI capabilities for customers. The report discusses the importance of public cloud providers in the ...

This report by Frost & Sullivan provides a comprehensive analysis of the North America Dedicated Internet Access (DIA) services market. Utilizing primary research interviews with leading service providers and secondary research from published materials, the study offers detailed revenue estimates and forecasts. The North America DIA market, current...